<?xml version="1.0" encoding="UTF-8"?>
<p>The positive note on the epitope-based universal vaccine efficacy in eliciting the robust immune responses at clinical trials underpins the immunomics in advancing the current vaccine development approaches to prevent infections from remerging or emerging highly evolving influenza viruses.</p>
